Fondaparinux is a medicine used to prevent blood clots after surgery. It helps stop your blood from clotting too much.
Every report comes from a Lived member, sent anonymously.
Have you tried Arixtra (Fondaparinux) for DVT (Deep Vein Thrombosis)?
Fondaparinux, sold under the brand name Arixtra and also available as a generic, is an injectable blood thinner (anticoagulant). Its main use is preventing deep vein thrombosis (DVT), a blood clot in a deep vein, usually in the leg, after surgeries that make such clots more likely: hip fracture repair, hip replacement, knee replacement and abdominal surgery. Preventing a DVT matters because part of the clot can break off and travel to the lungs, causing a pulmonary embolism (PE). It is also approved to treat a DVT or PE that has already formed in adults. In that case it covers the first days of treatment alongside warfarin, a blood thinner taken by mouth that takes several days to reach full effect. In children aged 1 year or older who weigh at least 10 kg (about 22 pounds), it is approved for treating clots. Hematologists sometimes use it off-label for heparin-induced thrombocytopenia (HIT), an immune reaction to heparin that lowers platelet counts and raises the risk of clots; a major hematology guideline lists fondaparinux among several non-heparin options for that situation.
Blood clotting is a chain reaction of proteins. One key link is Factor Xa, an enzyme that drives production of thrombin, the protein that builds a clot. The body has its own brake on this process, a natural protein called antithrombin. Fondaparinux is a small, lab-made molecule that attaches to antithrombin and makes it roughly 300 times better at neutralizing Factor Xa. With less Factor Xa active, less thrombin forms, and clots are less able to start or grow. Fondaparinux does not dissolve a clot that is already there, and it does not act on platelets directly. It is fully absorbed from under the skin, reaches its peak level within a few hours and is cleared almost entirely by the kidneys over about a day, which is why one injection a day is enough and why kidney function matters so much for its safety.
Fondaparinux comes in single-dose prefilled syringes and is injected once a day into the fatty tissue under the skin, usually of the belly, alternating between the left and right sides. It must never be injected into a muscle. Many people start it in the hospital; if injections continue at home, the care team decides whether that is appropriate and teaches the person or a caregiver the technique. The syringe contains a small air bubble that should not be pushed out before injecting, because doing so wastes some of the medicine. Used syringes go into a sharps container. The dose depends on the purpose. To prevent clots after surgery, adults receive a standard dose, with the first injection given no sooner than 6 to 8 hours after the operation, once bleeding is under control; starting earlier increases the risk of major bleeding. This usually continues for 5 to 9 days, and after hip fracture surgery the label recommends extending it by up to 24 more days. To treat an existing clot, the dose is based on body weight. Warfarin is started at the same time, and fondaparinux continues for at least 5 days and until a blood test called the INR (international normalized ratio, a measure of how long blood takes to clot) reaches 2 to 3. A higher INR means slower clotting, and 2 to 3 is the usual target range for warfarin. In children, the dose is calculated by weight and adjusted using blood tests of the drug level. If a dose is missed, inject it as soon as you remember, but never inject two doses at the same time.
Bleeding is the most important side effect. People often bruise more easily, small cuts may take longer to stop bleeding, and nosebleeds or bleeding at the injection site can occur. Irritation where the needle goes in, such as a small bruise, rash or itching, is also common. After hip or knee surgery, anemia (a low red blood cell count), dizziness and trouble sleeping were frequent in studies, at rates similar to enoxaparin, another injectable blood thinner used in the comparison. Tell the care team about unusual bleeding or bruising, and about a rash of tiny dark red spots under the skin, which can signal a drop in platelets, the blood cells that help stop bleeding. Call the care team right away for red or brown urine, red or black stools, vomit that is red or brown, coughing up blood, a severe headache or stomach pain, or dizziness and weakness. Bleeding that is heavy or will not stop, or any significant fall or blow to the head, needs urgent medical evaluation.
Fondaparinux carries a boxed warning, the strongest warning the US Food and Drug Administration (FDA) requires on a label, about spinal and epidural procedures. When someone taking it has a spinal or epidural anesthetic, or a spinal tap, bleeding can collect around the spinal cord and press on it, which can cause long-term or permanent paralysis. The risk is higher when an epidural catheter is left in place after surgery and when other medicines that affect clotting are also being taken. Surgical and anesthesia teams plan the timing of injections around these procedures. After one, back pain, numbness or tingling, weakness in the legs, or loss of bowel or bladder control needs immediate medical attention. Fondaparinux is not used in people with severe kidney impairment, meaning a creatinine clearance (an estimate of how well the kidneys filter blood) below 30 mL/min, because the drug builds up and bleeding risk rises; kidney function is checked during treatment. It is also not used to prevent clots after surgery in adults who weigh less than 50 kg (about 110 pounds), whose bleeding risk is higher. Other reasons not to use it include active major bleeding, bacterial endocarditis (an infection of the heart lining or valves), a previous serious allergic reaction to it, or a platelet drop linked to it. The Arixtra syringe's needle guard contains natural latex rubber, which matters for anyone with a latex allergy. Aspirin, NSAIDs (anti-inflammatory pain relievers such as ibuprofen), antiplatelet medicines such as clopidogrel, and other blood thinners all add to the bleeding risk. These are stopped before starting when possible; if one is truly needed, as warfarin is during clot treatment, the team watches more closely for bleeding. Tell every doctor and dentist about fondaparinux before surgery, dental work or a new medicine, including over-the-counter products. There is no known antidote that reverses fondaparinux, and its effect lasts 2 to 4 days after the last dose, longer when the kidneys work less well. In pregnancy, the label reports no clear link to birth defects, but the drug crosses the placenta in small amounts and could increase bleeding in the baby; as delivery approaches, switching to a shorter-acting blood thinner is usually considered. Little is known about its use while breastfeeding. Anyone pregnant, planning pregnancy or breastfeeding should discuss this with the prescriber.
For most people fondaparinux is a short course: about a week after surgery, up to about a month after hip fracture surgery, or roughly 5 to 9 days at the start of treatment for a clot until warfarin takes over. There is nothing to feel when it works; success means a clot does not form or grow. Most major bleeding in the surgical studies occurred in the first 4 days after the operation, which is why the timing of the first dose is handled carefully. Common clotting tests do not reliably measure fondaparinux's effect, so routine monitoring looks instead at blood counts (including platelets), kidney function and sometimes stool for hidden blood. People treating a clot also have INR tests for warfarin, and children have regular blood tests of the fondaparinux level itself. Talk with the prescriber before skipping injections or stopping early, and mention any planned procedure, since the drug's effect lingers for days.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Arixtra (Fondaparinux), what you've noticed, or ask the community a question.